MedTrace Logo

sTep dOWn Inhalers in the reAl woRlD

NCT03527927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 67

Last updated 2023-10-25

No results posted yet for this study

Summary

To establish the feasibility of stopping inhaled steroids and switching or maintaining dual bronchodilation in one visit - in the real world, for people with COPD.

Conditions

Interventions

DRUG

Any LABA/LAMA

Following consent, patients will be taken off their current ICS/LABA/LAMA combination inhalers and shown 4 single inhaler LABA/LAMA devices and asked to choose a preferred device to use, provided they can demonstrate effective use.

Sponsors & Collaborators

  • Swansea University

    collaborator OTHER

  • Hywel Dda Health Board

    lead OTHER

Principal Investigators

  • Keir E Lewis, Prof · Hywel Dda University Health Board

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-17
Primary Completion
2019-08-26
Completion
2019-08-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03527927 on ClinicalTrials.gov